Slapped Cheek and Parvovirus in Pregnancy

The numbers, with their source and their population

ACOG's practice advisory on parvovirus B19 gives the figures most people are looking for, and gives them with a gestational window attached.

"With acute parvovirus B19 infection during pregnancy, rates of maternal-to-fetal transmission range from 17% to 33%." "Most cases of fetal infection will resolve spontaneously; however, there is a 5-10% risk of adverse fetal outcomes, including fetal anemia, nonimmune hydrops, and fetal loss." And "the risk of adverse fetal outcomes is greatest if maternal infection occurs between 9 and 20 weeks of gestation."

Read those in order, because the sequence matters. They describe what follows a confirmed acute infection in the mother, not what follows an exposure. Most exposures do not lead to infection at all, because most adults are already immune. Then, of the pregnancies where the virus does cross to the baby, most resolve without intervention.

ACOG also notes that "as many as 20% of cases are asymptomatic", so a person who felt fine can still have been infectious.

Immunity is the first question

SMFM's update on parvovirus B19 sets out the testing logic clearly. Routine screening for immunity is not recommended in pregnancy, but serologic testing should be considered for pregnant people with symptoms compatible with infection, those with suspected fetal anaemia or nonimmune hydrops, and "asymptomatic pregnant people following confirmed exposure to parvovirus B19".

The result then splits you into two groups. If IgG is positive and IgM negative, you are immune, and SMFM says you "can be counseled regarding protective immunity and the unlikely risk of adverse fetal outcomes". If both are negative, you are not immune and can be monitored for symptoms or seroconversion. A positive IgM suggests recent infection and moves you into fetal monitoring.

Because a large proportion of adults are already immune from childhood infection, a single blood test resolves the worry for many people. Ask for it if you have had a confirmed exposure.

Why you should not leave work

This surprises people and it is worth stating explicitly. ACOG's advisory says that "exclusion of pregnant individuals from the workplace during endemic periods is not recommended", and explains why: "exposure cannot be eliminated by identifying and excluding individuals with acute parvovirus B19 infection because individuals are infectious before they develop symptoms".

By the time a child has the characteristic red cheeks, they are generally no longer infectious. Leaving a nursery or a classroom after an outbreak is announced protects nobody, because the exposure has already happened. If you work with young children and are pregnant, the useful actions are the ordinary respiratory precautions ACOG and SMFM list, and reporting confirmed exposures so you can be tested.

What to report, and how the UK handles it

In the UK, parvovirus B19 is covered by UKHSA's viral rash in pregnancy guidance, alongside measles, rubella and chickenpox, because these are the rash illnesses "where intervention can prevent or reduce the potential for adverse outcomes".

UKHSA's quick reference guidance asks pregnant women to inform their midwife, GP or obstetrician urgently if they develop a rash at any time in pregnancy, and to avoid antenatal clinics and maternity settings until assessed, to avoid exposing other pregnant women. It asks the same for contact with someone who has a rash, and defines contact for these purposes as "face-to-face contact or being in the same room (for example, house, classroom or 2 to 4 bed hospital bay) for a significant period (15 minutes or more)".

What gets tested is decided by the date of onset, the appearance and distribution of the rash, your gestation and your past history, in discussion with a microbiologist or virologist. So the single most useful thing you can supply is dates: when the contact was, when any rash or symptoms began.

What monitoring looks like if infection is confirmed

Treatment of the mother is supportive; there is no antiviral for parvovirus B19 and, as SMFM notes, no vaccine. The real work is watching the baby for anaemia.

That is done with serial ultrasound, using middle cerebral artery peak systolic velocity Doppler to detect fetal anaemia before hydrops develops, typically weekly for a period of weeks after confirmed maternal infection. If significant fetal anaemia is found, intrauterine transfusion is the treatment, and it is effective. SMFM's related clinical guidelines cover fetal blood sampling, nonimmune hydrops and the fetus at risk of anaemia.

This is the reason confirming infection matters even though nothing can be done about the maternal illness: it switches on surveillance that can detect and treat a complication that would otherwise be found too late.

If you have sickle cell disease or another blood condition

The NHS pages on slapped cheek syndrome flag this specifically. If you have a blood disorder such as sickle cell disease or thalassaemia, parvovirus B19 carries a risk of severe anaemia in you, because the virus temporarily suppresses red cell production. The NHS advises seeing a GP if you think you have slapped cheek syndrome and have such a condition, and urgent advice if you develop very pale skin or shortness of breath. ACOG's advisory likewise notes an increased number of reported cases in people with sickle cell disease.

Keeping the risk in proportion

The honest summary is that a rash contact in pregnancy is worth reporting and worth a blood test, and that for the substantial proportion of women who turn out to be immune the story ends there. For those who are infected, most babies are unaffected, a minority develop anaemia, and that anaemia is detectable and treatable. The NHS pages describe slapped cheek syndrome as usually mild, and for the person who has it, it usually is.